MARGINAL ZONE B-CELL LYMPHOMA
Clinical trials for MARGINAL ZONE B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new MARGINAL ZONE B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for MARGINAL ZONE B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cord blood transplant shows promise for tough blood cancers
Disease control TerminatedThis study looked at using umbilical cord blood transplants after strong chemotherapy and radiation to treat various blood cancers like leukemia and lymphoma. It included 200 people and aimed to see how many survived one year after the transplant. The approach is intense and mean…
Matched conditions: MARGINAL ZONE B-CELL LYMPHOMA
Phase: NA • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated May 26, 2026 08:20 UTC
-
Lymphoma drug combo shows promise in early trial
Disease control TerminatedThis study tested a combination of two drugs, umbralisib and rituximab, as the first treatment for people with follicular lymphoma or marginal zone lymphoma. The goal was to see how many patients had their cancer completely disappear. The study was stopped early and included 18 a…
Matched conditions: MARGINAL ZONE B-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Apr 24, 2026 16:19 UTC